Search - tctmd.com

Displaying 321 - 340 of 456

Sort: Relevancy | Date

Presentation TCT 2017

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Presenter: Robert O. Bonow, Michael J. Mack, Elazer R. Edelman

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Conclusion - How I Treated This Case

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Presentation TCT 2017

Germany Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Thomas Walther

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Presentation TCT 2017

Poland Presents: Case Conclusion - How I Treated This Case

Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Czech Republic Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Marian Branny

October 30, 2017

Presentation TCT 2017

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Presenter: Petr Kala, Jochen Wöhrle, Martin Hudec

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey V: Addressing Complications and Follow-up

Presenter: Martina Kelly Speight, Amy E. Simone

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey IV: The Hospital Experience

Presenter: Martina Kelly Speight, Sandra Lauck

October 30, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey III: Behind the Scenes

Presenter: Martina Kelly Speight, Sarah Clarke

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey II: Imaging Assessment

Presenter: Martina Kelly Speight, João L Cavalcante

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey I: Initial Evaluation

Presenter: Martina Kelly Speight, Patricia Keegan

October 30, 2017

Presentation TCT 2017

Step-By-Step TAVR Implantation Technique (Case-based)

Presenter: Alexandre Abizaid, Oscar A. Mendiz

October 29, 2017

Presentation TCT 2017

Interventional Pathobiology: A Practical Anatomical Description for SHD Procedures

Presenter: Alexandre Abizaid, Oscar A. Mendiz, Juan F. Granada

October 29, 2017

Advertisement

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Slovakia Presents: Case Conclusion - How I Treated This Case

Germany Comments: How Would I Treat This Case and Why?

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Poland Presents: Case Conclusion - How I Treated This Case

Czech Republic Comments: How Would I Treat This Case and Why?

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

TAVR Patient Journey V: Addressing Complications and Follow-up

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

TAVR Patient Journey IV: The Hospital Experience

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

TAVR Patient Journey III: Behind the Scenes

TAVR Patient Journey II: Imaging Assessment

TAVR Patient Journey I: Initial Evaluation

Step-By-Step TAVR Implantation Technique (Case-based)

Interventional Pathobiology: A Practical Anatomical Description for SHD Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content